Skip Navigation

Cardiovascular Research 2002 54(1):105-116; doi:10.1016/S0008-6363(02)00230-4
© 2002 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Chu, G.
Right arrow Articles by Kranias, E. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chu, G.
Right arrow Articles by Kranias, E. G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2002, European Society of Cardiology

Enhanced myocyte contractility and Ca2+ handling in a calcineurin transgenic model of heart failure

Guoxiang Chua,1, Andrew N. Carra,1, Karen B. Younga, J.William Lestera, Atsuko Yatania, Atsushi Sanbec, Melissa C. Colbertc, Steven M. Schwartzc, Konrad F. Franka, Paul D. Lampeb, Jeffrey Robbinsc, Jeffery D. Molkentinc and Evangelia G. Kraniasa,*

aDepartment of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, 231 Albert B. Sabin Way, Cincinnati, OH 45267-0575, USA
bFred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
cChildren's Hospital Medical Center, Cincinnati, OH 45229, USA

litsa.kranias{at}uc.edu

* Corresponding author. Tel.: +1-513-558-2377; fax: +1-513-558-2269

Objective: Impaired myocyte Ca2+ handling is a common characteristic of failing hearts and increases in calcineurin activity, a Ca2+-sensitive phosphatase, have been implicated in heart failure phenotype. Transgenic mice with cardiac-specific expression of an active form of calcineurin display depressed function, hypertrophy and heart failure. We examined whether defects in cardiomyocyte Ca2+ handling properties contribute to the impaired cardiac function in calcineurin transgenic mice. Methods: The levels of SR Ca2+ handling proteins, SR Ca2+ transport function and cardiomyocyte mechanics, as well as Ca2+ kinetics were examined in mice overexpressing a constitutively active form of calcineurin. Results: Transgenic expression of activated calcineurin catalytic subunit resulted in significant protein increases (66%) in SERCA2 and decreases (35%) in phospholamban, as well as enhanced (~80%) phospholamban phosphorylation. These alterations in the SR Ca2+-transport proteins resulted in increased Vmax and Ca2+-affinity of SERCA2. The myofibrillar Mg-ATPase activity was also significantly increased at pCa>6.0. The enhanced SR Ca2+ handling and Mg-ATPase activity reflected significant elevation in myocyte contractile parameters (3-fold), Ca2+ transient amplitude (1.5-fold) and the rate of Ca2+ signal decay (2-fold). In contrast, in vivo cardiac function assessed by echocardiography, indicated severely depressed contractility in calcineurin hearts. The apparent disparity in contractile properties between the cellular and multicellular preparations may be partially due to tissue remodeling, including interstitial fibrosis and a marked reduction (45%), dephosphorylation (81%) and redistribution of the gap junctional protein connexin-43, which could compromise intercellular communication. Conclusion: Despite enhanced SR Ca2+ handling and contractility in myocytes, pathological remodeling and defects in intercellular coupling may underlie contractile dysfunction of the calcineurin hearts.

KEYWORDS Calcium (cellular); Contractile function; Heart failure; Hypertrophy; Myocytes; SR (function)


1 Both authors contributed equally to this work.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. J. Gelpi, S. Gao, P. Zhai, L. Yan, C. Hong, L. M. A. Danridge, H. Ge, Y. Maejima, M. Donato, M. Yokota, et al.
Genetic inhibition of calcineurin induces diastolic dysfunction in mice with chronic pressure overload
Am J Physiol Heart Circ Physiol, November 1, 2009; 297(5): H1814 - H1819.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. M. Wolska
Calcineurin and cardiac function: is more or less better for the heart?
Am J Physiol Heart Circ Physiol, November 1, 2009; 297(5): H1576 - H1577.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. J. Schaeffer, J. DeSantiago, J. Yang, T. P. Flagg, A. Kovacs, C. J. Weinheimer, M. Courtois, T. C. Leone, C. G. Nichols, D. M. Bers, et al.
Impaired contractile function and calcium handling in hearts of cardiac-specific calcineurin b1-deficient mice
Am J Physiol Heart Circ Physiol, October 1, 2009; 297(4): H1263 - H1273.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. M. Prasad and G. Inesi
Effects of thapsigargin and phenylephrine on calcineurin and protein kinase C signaling functions in cardiac myocytes
Am J Physiol Cell Physiol, May 1, 2009; 296(5): C992 - C1002.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. K. Mork, I. Sjaastad, O. M. Sejersted, and W. E. Louch
Slowing of cardiomyocyte Ca2+ release and contraction during heart failure progression in postinfarction mice
Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H1069 - H1079.
[Abstract] [Full Text] [PDF]


Home page
Circ Heart FailHome page
K. Toischer, H. Kogler, G. Tenderich, C. Grebe, T. Seidler, P. N. Van, K. Jung, R. Knoll, R. Korfer, and G. Hasenfuss
Elevated Afterload, Neuroendocrine Stimulation, and Human Heart Failure Increase BNP Levels and Inhibit Preload-Dependent SERCA Upregulation
Circ Heart Fail, November 1, 2008; 1(4): 265 - 271.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Totzeck, K. Boengler, A. van de Sand, I. Konietzka, P. Gres, D. Garcia-Dorado, G. Heusch, and R. Schulz
No impact of protein phosphatases on connexin 43 phosphorylation in ischemic preconditioning
Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H2106 - H2112.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. R. Somers, P. L. Beck, J. P. Lees-Miller, D. Roach, Y. Li, J. Guo, S. Loken, S. Zhan, L. Semeniuk, and H. J. Duff
iNOS in cardiac myocytes plays a critical role in death in a murine model of hypertrophy induced by calcineurin
Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1122 - H1131.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
I. Pinz, S. E. Ostroy, K. Hoyer, H. Osinska, J. Robbins, J. D. Molkentin, and J. S. Ingwall
Calcineurin-induced energy wasting in a transgenic mouse model of heart failure
Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1459 - H1466.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. M. MacDonnell, H. Kubo, D. M. Harris, X. Chen, R. Berretta, M. F. Barbe, S. Kolwicz, P. O. Reger, A. Eckhart, B. F. Renna, et al.
Calcineurin inhibition normalizes beta-adrenergic responsiveness in the spontaneously hypertensive rat
Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H3122 - H3129.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
U. Kirchhefer, J. Klimas, H. A. Baba, I. B. Buchwalow, L. Fabritz, M. Huls, M. Matus, F. U. Muller, W. Schmitz, and J. Neumann
Triadin is a critical determinant of cellular Ca cycling and contractility in the heart
Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H3165 - H3174.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
L. P. Collis, M. B. Meyers, J. Zhang, C. K. L. Phoon, E. A. Sobie, W. A. Coetzee, and G. I. Fishman
Expression of a sorcin missense mutation in the heart modulates excitation-contraction coupling
FASEB J, February 1, 2007; 21(2): 475 - 487.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. L. Valencik, D. Zhang, B. Punske, P. Hu, J. A. McDonald, and S. E. Litwin
Integrin Activation in the Heart: A Link Between Electrical and Contractile Dysfunction?
Circ. Res., December 8, 2006; 99(12): 1403 - 1410.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Guo, S. Zhan, J. Somers, R. E. Westenbroek, W. A. Catterall, D. E. Roach, R. S. Sheldon, J. P. Lees-Miller, P. Li, Y. Shimoni, et al.
Decrease in density of INa is in the common final pathway to heart block in murine hearts overexpressing calcineurin
Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2669 - H2679.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Kogler, P. Schott, K. Toischer, H. Milting, P. N. Van, M. Kohlhaas, C. Grebe, A. Kassner, E. Domeier, N. Teucher, et al.
Relevance of Brain Natriuretic Peptide in Preload-Dependent Regulation of Cardiac Sarcoplasmic Reticulum Ca2+ ATPase Expression
Circulation, June 13, 2006; 113(23): 2724 - 2732.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
M. Rubio, I. Bodi, G. A. Fuller-Bicer, H. S. Hahn, M. Periasamy, and A. Schwartz
Sarcoplasmic Reticulum Adenosine Triphosphatase Overexpression in the L-type Ca2+ Channel Mouse Results in Cardiomyopathy and Ca2+-Induced Arrhythmogenesis
Journal of Cardiovascular Pharmacology and Therapeutics, October 1, 2005; 10(4): 235 - 249.
[Abstract] [PDF]


Home page
Cardiovasc ResHome page
U. Kirchhefer, H. A. Baba, P. Boknik, K. M. Breeden, N. Mavila, N. Bruchert, I. Justus, M. Matus, W. Schmitz, A. A. DePaoli-Roach, et al.
Enhanced cardiac function in mice overexpressing protein phosphatase Inhibitor-2
Cardiovasc Res, October 1, 2005; 68(1): 98 - 108.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. D. Spragg and D. A. Kass
Controlling the Gap: Myocytes, Matrix, and Mechanics
Circ. Res., March 18, 2005; 96(5): 485 - 487.
[Full Text] [PDF]


Home page
Eur Heart JHome page
B. E.J. Teunissen, H. J. Jongsma, and M. F.A. Bierhuizen
Regulation of myocardial connexins during hypertrophic remodelling
Eur. Heart J., November 2, 2004; 25(22): 1979 - 1989.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. Vlasblom, A. Muller, R. J.P Musters, M. J Zuidwijk, C. van Hardeveld, W. J Paulus, and W. S Simonides
Contractile arrest reveals calcium-dependent stimulation of SERCA2a mRNA expression in cultured ventricular cardiomyocytes
Cardiovasc Res, August 15, 2004; 63(3): 537 - 544.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. M Janczewski, M. Zahid, B. H Lemster, C. S Frye, G. Gibson, Y. Higuchi, E. G Kranias, A. M Feldman, and C. F McTiernan
Phospholamban gene ablation improves calcium transients but not cardiac function in a heart failure model
Cardiovasc Res, June 1, 2004; 62(3): 468 - 480.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. B. Vega, R. Bassel-Duby, and E. N. Olson
Control of Cardiac Growth and Function by Calcineurin Signaling
J. Biol. Chem., September 26, 2003; 278(39): 36981 - 36984.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Li, A. Yatani, S.-J. Kim, G. Takagi, K. Irie, Q. Zhang, V. Karoor, C. Hong, G. Yang, J. Sadoshima, et al.
Neurally-mediated increase in calcineurin activity regulates cardiac contractile function in absence of hypertrophy
Cardiovasc Res, September 1, 2003; 59(3): 649 - 657.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. R. Houser and K. B. Margulies
Is Depressed Myocyte Contractility Centrally Involved in Heart Failure?
Circ. Res., March 7, 2003; 92(4): 350 - 358.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.